Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
5
×
national blog main
biotech
national top stories
san francisco blog main
innovation
life sciences
new york blog main
raleigh-durham blog main
baird capital
boston blog main
cancer diagnostics
deals
medical device
orbimed
san diego blog main
san francisco
san francisco top stories
software
startups
venture capital
10x genomics
abbvie
accelerator
actavalon
acute myeloid leukemia
aileron therapeutics
analytics
apps
aprea therapeutics
arboretum ventures
arimoclomol
arlington
armo biosciences
arnold levine
astellas pharma
at&t foundry
at&t stadium
aurora health care
austin
What
company
5
×
expand
files
ipo
public
tests
adding
advance
aims
ann
arbor
austin
awarded
baird
based
biologics
biology
biotech
blood
broader
cancer
caught
closed
cprit
cytokine
deal
decisions
detect
developing
diagnostic
diagnostics
drive.ai
drugs
enhanced
firms
fold
forbius
formation
grail
grants
Language
unset
Current search:
xconomy.com
×
cancer
×
company
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
CPRIT Grants, TMC & Baird, Shipt & Drive.ai Expand, & More TX Tech
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
